Respiratory Infections News

Experts are learning about long COVID, a mysterious syndrome that the CDC describes as “new, returning, or ongoing health problems” that occur 4 or more weeks after a person is initially infected with SARS-CoV-2.

A CDC advisory committee said that it strongly supports the continued use of the Johnson & Johnson COVID-19 vaccine, despite its potential link to Guillain-Barré syndrome.

Provisional data from the CDC revealed a 1.5-year decline in life expectancy in the United States from 2019 to 2020.

According to scientists from the University of Alabama at Birmingham, only a small number of COVID-19 vaccines in development are given as nasal sprays, despite the technology’s potential to block SARS-CoV-2 transmission at the source.

As researchers try to determine who is most at risk for long COVID-19, evidence suggests that it is more common among women than men.

Among the many health consequences of COVID-19, there remain a few mysteries, including what causes the long-term, postacute sequelae known as long COVID.

On my first day of medical school, I was assigned a physical diagnosis tutor who was a well-known infectious diseases specialist. He had encyclopedic knowledge. He was a remarkable teacher and — equally important — a great storyteller.

The FDA recently approved Vaxneuvance, Merck’s 15-valent pneumococcal conjugate vaccine, for adults aged 18 years or older.

Findings from the 6-month ZeNix trial indicated that a three-drug regimen for highly resistant tuberculosis was safer and just as effective when it included reduced doses or shorter durations of linezolid, researchers reported.

The AAP said Monday that everyone aged 2 years or older should wear a mask in school, regardless COVID-19 vaccination status, because many students are not eligible for vaccination and it is difficult to tell who has been immunized.